Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

zydelig_gilead

Gilead cancer boss departs after safety concerns halt Zydelig trials

March 18, 2016 Medical Communications, Research and Development Gilead Sciences, zydelig

In the wake of the halting of six clinical trials of its blood cancer drug Zydelig due to safety concerns, …
News

Kite Pharma, Roche to co-develop two new treatments for non-hodgkin lymphoma

March 18, 2016 Medical Communications, Research and Development Gentech, Roche, kite pharma, non-Hodgkin lymphoma

Kite Pharma (Nasdaq: KITE) said it will collaborate with Swiss drug major Roche (SIX: ROG) to evaluate the safety and efficacy …
News

Building trust and loyalty in medical communications – London-based agency reveal their approach

March 17, 2016 Medical Communications Synergy Vision, graduate recruitment, medical communications, medical communications agency, recruitment, retention

There has always been a high turnover of staff within the medical communications industry – a recent survey on the …
News
Press release
chugai_pharmaceutical

Chugai receive orphan drug status for autoimmune disease treatment

March 17, 2016 Manufacturing and Production, Medical Communications, Research and Development chuagi, systemic scleroderma, tocilizumab

Chugai Pharmaceutical Co. (TYO: 4519) has received a notification of orphan drug designation, from the Japanese minister of health, labour …
News

Sir Andrew Witty announces decision to step down as CEO of GSK

March 17, 2016 Medical Communications, Research and Development Andrew Witty, GSK, GlaxoSmithKline, Neil Woodford, Sir Andrew Witty, Witty, gsk break up, gsk split, retirement, steps down

Sir Andrew Witty has announced his decision to retire from his role as chief executive officer of pharmaceutical giant, GlaxoSmithKline …
News
gsk_l_rgb-web

GSK establish cell and gene therapy collaboration with Miltenyi Biotec

March 16, 2016 Medical Communications, Research and Development GSK, GlaxoSmithKline, cell and gene therapy, collaboration, miltenyi biotec

GlaxoSmithKline (NYSE:GSK) has announced a strategic collaboration with Miltenyi Biotec that will see GSK’s expertise in developing cell and gene …
News
aedes_aegypti_mosquito

New research supports association between Zika virus and microcephaly

March 16, 2016 Medical Communications, Research and Development Lancet, Zika virus, french polynesia, microcephaly, outbreak

Using data from the 2013-14 outbreak of Zika virus in French Polynesia, new research in The Lancet has further supported …
News
bruce_roberts_vedanta

PureTech’s Vedanta Biosciences appoints former Genzyme VP chief scientific officer

March 16, 2016 Medical Communications, Research and Development Bruce Roberts, Genzyme, Vedanta Biosciences

Vedanta Biosciences, a company developing therapies designed to modulate the human microbiome, has appointed former Genzyme group vice president, Bruce …
Appointment
vascepa

COMMENT: What does Amarin’s off-patent victory over the FDA mean for the industry?

March 14, 2016 Medical Communications, Sales and Marketing Amarin, FDA, off label, off-label, vascepa

Last week, Pharmafile.com reported that small biopharma Amarin had settled litigation with US drugs regulator the FDA that will allow …
Feature

MSF challenges Pfizer’s pneumonia vaccine patent in India

March 11, 2016 Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine

The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
News
grifolslogo

Spanish firm Grifols to spend a total of $360 million on four new plants

March 11, 2016 Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production

Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
News
facilities_lg06

Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey

March 11, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration

Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …
News
spark_logo

Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal

March 11, 2016 Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions

Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …
News
shutterstock_38078521

US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump

March 11, 2016 Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA

Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
News
valeant_sign

US Congress Committee pressures Valeant to produce drug pricing documents

March 11, 2016 Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026